Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10005352HBVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS30077759HIVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS30086944HIVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS30085367HIVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS30034193HIVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20050828HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20050514HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20025606HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20025607HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TVIS20031456HPVENSG00000089250.20protein_codingNOS1NoNo4842A0PJJ7
B3VK56
P29475
TCGA Plot Options
Drug Information
GeneNOS1
DrugBank IDDB01942
Drug NameFormic acid
Target IDBE0000067
UniProt IDP29475
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsExperimental; Investigational
Direct ClassificationCarboxylic acids
SMILES[H]C(O)=O
PathwaysCerivastatin Action Pathway; Desmosterolosis; Pamidronate Action Pathway; Ibandronate Action Pathway; 17-beta Hydroxysteroid Dehydrogenase III Deficiency; DOPA-Responsive Dystonia; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Pterine Biosynthesis; Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps); Hypercholesterolemia; Risedronate Action Pathway; Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency; Mevalonic Aciduria; Tryptophan Metabolism; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; Cholesteryl Ester Storage Disease; Androgen and Estrogen Metabolism; Lovastatin Action Pathway; Folate Metabolism; Aromatase Deficiency; Methylenetetrahydrofolate Reductase Deficiency (MTHFRD); Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway
PharmGKBPA449705
ChEMBLCHEMBL116736